PRRT2 and Hyperglycemia: Hyperglycemia leads to the accumulation of ROS in tissues or cells with different metabolic pathways, such as activation of the polyol pathway, formation of advanced glycation end products (AGEs) and activation of its receptor, activation of isoform protein kinase C (PKC), increased activity of hexosamine pathway, and decreased antioxidant defenses.